Trials / Completed
CompletedNCT01692873
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
Research for Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors - PACAomics / IPC 2011-004
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 274 (actual)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Pancreatic cancer is among the most serious human neoplasia and the most difficult to treat. Most patients present at diagnosis a non resectable, locally advanced or metastatic disease, with a median survival of 12 month. The aim of this study is the identification of diagnosis biomarkers, predictive of the therapeutic response. This project investigate the use of molecular analyses applied to pancreatic tumor cells collected by microbiopsy under ultrasound-endoscopy, and blood cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | suspected pancreatic tumor | Realization of pancreatic surgery to obtain tumor biopsy and blood samples to realize biomarkers analyses. |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2012-09-25
- Last updated
- 2018-08-14
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01692873. Inclusion in this directory is not an endorsement.